Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vondrácek, J.
Right arrow Articles by Kozubík, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vondrácek, J.
Right arrow Articles by Kozubík, A.
(Journal of Leukocyte Biology. 2001;69:794-802.)
© 2001 by Society for Leukocyte Biology

Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells

Jan Vondrácek*, Michael A. Sheard2, Pavel Krejcí3, Katerina Minksová*, Jirina Hofmanová* and Alois Kozubík*

* Institute of Biophysics,
{dagger} Masaryk Memorial Cancer Institute, and
{ddagger} Laboratory of Molecular Embryology, Mendel University, Brno, Czech Republic

Correspondence: Jan Vondrácek, Institute of Biophysics, Královopolská 135, 612 65 Brno, Czech Republic. E-mail: hivrisek{at}ibp.cz

Differentiating myeloid cells may become resistant to various apoptotic stimuli. In the present study, dimethyl sulfoxide (DMSO) and all-trans retinoic acid (ATRA) were found to modulate the sensitivity of HL-60 cells to death receptor-mediated apoptosis in a time-dependent manner. During the early stages of differentiation, DMSO treatment increased the response of HL-60 cells to tumor necrosis factor {alpha}; (TNF-{alpha}), but enhanced responsiveness was lost during later differentiation stages. In contrast, ATRA treatment induced resistance to TNF-{alpha}-induced apoptosis. HL-60 cells were resistant to Fas-mediated apoptosis but were sensitized by culturing in serum-free conditions. Similar to its effect on TNF-{alpha} sensitivity, DMSO pretreatment augmented the response to Fas-mediated signaling, which coincided with increased expression of Fas on DMSO-pretreated cells. However, during the later stages of DMSO-induced differentiation, sensitivity to anti-Fas antibody-induced apoptosis declined significantly, although Fas expression was still elevated. The reduced sensitivity to anti-Fas treatment partially correlated with increased Fas-associated phosphatase-1 mRNA expression. Thus, regardless of either Fas up-regulation or potentiation of TNF-{alpha}-mediated apoptosis during early DMSO-induced differentiation, a slow increase in resistance to apoptosis mediated through these death receptors occurs during DMSO-induced differentiation, which contrasts with the rapid induction of resistance following treatment with ATRA.

Key Words: all-trans retinoic acid • dimethyl sulfoxide • Fas/CD95/APO-1 • TNF-{alpha} • Bcl-2 • FAP-1




This article has been cited by other articles:


Home page
BloodHome page
D. J. Park, P. T. Vuong, S. de Vos, D. Douer, and H. P. Koeffler
Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays
Blood, November 15, 2003; 102(10): 3727 - 3736.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Hietakangas, M. Poukkula, K. M. Heiskanen, J. T. Karvinen, L. Sistonen, and J. E. Eriksson
Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP
Mol. Cell. Biol., February 15, 2003; 23(4): 1278 - 1291.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Leukocyte Biology.